Literature DB >> 35308750

Choriocarcinoma After Full-Term Pregnancy: A Case Report and Review of the Literature.

Emmanouil Katsanevakis1, Alice Oatham2, Darly Mathew2.   

Abstract

Choriocarcinoma is a disease associated with uncontrollable proliferation and malignant change of cells of the placenta and belongs to the malignant end of the spectrum in gestational trophoblastic disease. These tumours are usually developed after molar pregnancies, and their incidence after full-term pregnancies is extremely rare. We present a very rare case of a 30-year-old lady, admitted with a five-month history of vaginal bleeding after a normal pregnancy. The human chorionic gonadotropin (hCG) was at a level of 209,566. A pelvic ultrasound scan revealed an endometrial thickness of 6 cm and the presence of an intra-uterine mass measuring 56 × 50 × 45 mm. After discussion with the regional gestational trophoblastic disease centre, we proceeded to a surgical evacuation of the uterus, which confirmed a post-partum choriocarcinoma (International Federation of Gynaecology and Obstetrics (FIGO) score 9). Care was continued in the specialised centre with multi-agent chemotherapy. The response was excellent, and the patient was subsequently discharged after 10 cycles of chemotherapy, and a 10-year follow-up was arranged. Choriocarcinomas after full-term pregnancies are a rare entity. Even when they happen, they are usually associated with pregnancy complications in the ante-natal period. The prognosis is usually very good, provided that prompt diagnosis and referral to a specialised centre are made. Low-risk patients are usually treated with methotrexate monotherapy, whereas high-risk women would normally require multi-agent chemotherapy. The diagnosis of choriocarcinoma might be proven challenging even for experienced clinicians. Women should be informed that the prognosis is usually excellent, provided that they receive the right treatment.
Copyright © 2022, Katsanevakis et al.

Entities:  

Keywords:  choriocarcinoma; gestational trophoblastic diease; gestational trophoblastic neoplasia; invasive molar pregnancy; post-partum hemorrhage

Year:  2022        PMID: 35308750      PMCID: PMC8925935          DOI: 10.7759/cureus.22200

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

1.  Trends in gestational choriocarcinoma: a 27-year perspective.

Authors:  Harriet O Smith; Clifford R Qualls; Beth A Prairie; Luis A Padilla; William F Rayburn; Charles R Key
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

2.  Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  M J Seckl; N J Sebire; R A Fisher; F Golfier; L Massuger; C Sessa
Journal:  Ann Oncol       Date:  2013-09-01       Impact factor: 32.976

Review 3.  Chorionic tumors.

Authors:  R S Berkowitz; D P Goldstein
Journal:  N Engl J Med       Date:  1996-12-05       Impact factor: 91.245

Review 4.  Gestational trophoblastic disease.

Authors:  Michael J Seckl; Neil J Sebire; Ross S Berkowitz
Journal:  Lancet       Date:  2010-07-29       Impact factor: 79.321

5.  Choriocarcinoma after a nonterm pregnancy.

Authors:  Madeleine C Macdonald; Ramachandran Ram; John A Tidy; Barry W Hancock
Journal:  J Reprod Med       Date:  2010 May-Jun       Impact factor: 0.142

6.  Management of Gestational Trophoblastic Disease: Green-top Guideline No. 38 - June 2020.

Authors: 
Journal:  BJOG       Date:  2020-09-29       Impact factor: 6.531

7.  Choriocarcinoma After Normal Vaginal Delivery; A Rare Entity.

Authors:  Aziz Un Nisa Abbasi; Anisa Fawad; Ansa Islam; Ayesha Ismail; Obaid Ullah
Journal:  J Ayub Med Coll Abbottabad       Date:  2019 Oct-Dec

Review 8.  Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature.

Authors:  Karthik A Ganapathi; Tamera Paczos; Mary D George; Samuel Goodloe; Lucia L Balos; Frank Chen
Journal:  Int J Gynecol Pathol       Date:  2010-09       Impact factor: 2.762

9.  Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.

Authors:  Philip Savage; Rosie Cooke; Jenny O'Nions; Jon Krell; Amy Kwan; Michelle Camarata; Gairin Dancy; Dee Short; Michael J Seckl; Anthony Swerdlow
Journal:  J Clin Oncol       Date:  2014-12-29       Impact factor: 44.544

10.  Presentation and management of choriocarcinoma after nonmolar pregnancy.

Authors:  J A Tidy; G J Rustin; E S Newlands; M Foskett; S Fuller; D Short; P Rowden
Journal:  Br J Obstet Gynaecol       Date:  1995-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.